110 related articles for article (PubMed ID: 1752491)
21. Chemotherapy and extended-field radiation therapy to para-aortic area in patients with histologically proven metastatic cervical cancer to para-aortic nodes: a phase II pilot study.
Husseinzadeh N; Shrake P; DeEulis T; Rowley K; Aron B
Gynecol Oncol; 1994 Mar; 52(3):326-31. PubMed ID: 8157190
[TBL] [Abstract][Full Text] [Related]
22. Induction chemotherapy followed by concurrent chemoradiation in advanced squamous cell carcinoma of the head and neck: final results from a phase II study with docetaxel, cisplatin and 5-fluorouracil with a four-year follow-up.
Rapidis AD; Trichas M; Stavrinidis E; Roupakia A; Ioannidou G; Kritselis G; Liossi P; Giannakouras G; Douzinas EE; Katsilieris I
Oral Oncol; 2006 Aug; 42(7):675-84. PubMed ID: 16731029
[TBL] [Abstract][Full Text] [Related]
23. Role of mitomycin C in the development of late bowel toxicity following chemoradiation for locally advanced carcinoma of the cervix.
Rakovitch E; Fyles AW; Pintilie M; Leung PM
Int J Radiat Oncol Biol Phys; 1997 Jul; 38(5):979-87. PubMed ID: 9276362
[TBL] [Abstract][Full Text] [Related]
24. Pelvic irradiation with concurrent chemotherapy versus pelvic and para-aortic irradiation for high-risk cervical cancer: an update of radiation therapy oncology group trial (RTOG) 90-01.
Eifel PJ; Winter K; Morris M; Levenback C; Grigsby PW; Cooper J; Rotman M; Gershenson D; Mutch DG
J Clin Oncol; 2004 Mar; 22(5):872-80. PubMed ID: 14990643
[TBL] [Abstract][Full Text] [Related]
25. Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer.
Morris M; Eifel PJ; Lu J; Grigsby PW; Levenback C; Stevens RE; Rotman M; Gershenson DM; Mutch DG
N Engl J Med; 1999 Apr; 340(15):1137-43. PubMed ID: 10202164
[TBL] [Abstract][Full Text] [Related]
26. Concurrent chemoradiotherapy with paclitaxel and nedaplatin followed by consolidation chemotherapy in locally advanced squamous cell carcinoma of the uterine cervix: preliminary results of a phase II study.
Zhang MQ; Liu SP; Wang XE
Int J Radiat Oncol Biol Phys; 2010 Nov; 78(3):821-7. PubMed ID: 20207507
[TBL] [Abstract][Full Text] [Related]
27. Low-dose-rate californium-252 neutron intracavitary afterloading radiotherapy combined with conformal radiotherapy for treatment of cervical cancer.
Zhang M; Xu HD; Pan SD; Lin S; Yue JH; Liu JR
Int J Radiat Oncol Biol Phys; 2012 Jul; 83(3):966-71. PubMed ID: 22138462
[TBL] [Abstract][Full Text] [Related]
28. Interim results of a randomized trial of mitomycin C as an adjunct to radical radiotherapy in the treatment of locally advanced squamous-cell carcinoma of the cervix.
Roberts KB; Urdaneta N; Vera R; Vera A; Gutierrez E; Aguilar Y; Ott S; Medina I; Sempere P; Rockwell S; Sartorelli AC; Fischer DB; Fischer JJ
Int J Cancer; 2000 Aug; 90(4):206-23. PubMed ID: 10993961
[TBL] [Abstract][Full Text] [Related]
29. Treatment of 29 patients with bulky squamous cell carcinoma of the cervix with simultaneous cisplatin, 5-fluorouracil, and split-course hyperfractionated radiation therapy.
Heaton D; Yordan E; Reddy S; Bonomi P; Lee MS; Lincoln S; Graham J; Dolan T; Miller A; Phillips A
Gynecol Oncol; 1990 Sep; 38(3):323-7. PubMed ID: 2227542
[TBL] [Abstract][Full Text] [Related]
30. A phase II trial of mitomycin, vincristine, bleomycin, and cisplatin (MOBP) as neoadjuvant therapy in high-risk cervical carcinoma.
Weiner SA; Aristizabal S; Alberts DS; Surwit EA; Deatherage-Deuser K
Gynecol Oncol; 1988 May; 30(1):1-6. PubMed ID: 2452769
[TBL] [Abstract][Full Text] [Related]
31. Final results of a phase II chemoradiation protocol for locally advanced cervical cancer: RTOG 85-15.
John M; Flam M; Caplan R; Rotman M; Quivey J; Steinfeld A; Russell A
Gynecol Oncol; 1996 May; 61(2):221-6. PubMed ID: 8626137
[TBL] [Abstract][Full Text] [Related]
32. Combined chemoradiation therapy for anal cancer. A report of 56 cases.
Doci R; Zucali R; Bombelli L; Montalto F; Lamonica G
Ann Surg; 1992 Feb; 215(2):150-6. PubMed ID: 1546901
[TBL] [Abstract][Full Text] [Related]
33. Neoadjuvant intraarterial chemotherapy followed by radical hysterectomy and/or radiotherapy for locally advanced cervical cancer.
Sugiyama T; Nishida T; Hasuo Y; Fujiyoshi K; Yakushiji M
Gynecol Oncol; 1998 May; 69(2):130-6. PubMed ID: 9600820
[TBL] [Abstract][Full Text] [Related]
34. Concurrent chemoradiation in advanced cervical cancer.
Thomas G; Dembo A; Fyles A; Gadalla T; Beale F; Bean H; Pringle J; Rawlings G; Bush R; Black B
Gynecol Oncol; 1990 Sep; 38(3):446-51. PubMed ID: 2227560
[TBL] [Abstract][Full Text] [Related]
35. A Phase II study of acute toxicity for Celebrex (celecoxib) and chemoradiation in patients with locally advanced cervical cancer: primary endpoint analysis of RTOG 0128.
Gaffney DK; Winter K; Dicker AP; Miller B; Eifel PJ; Ryu J; Avizonis V; Fromm M; Greven K
Int J Radiat Oncol Biol Phys; 2007 Jan; 67(1):104-9. PubMed ID: 17084549
[TBL] [Abstract][Full Text] [Related]
36. The long-term efficacy of neoadjuvant chemotherapy followed by radical hysterectomy compared with radical surgery alone or concurrent chemoradiotherapy on locally advanced-stage cervical cancer.
Yin M; Zhao F; Lou G; Zhang H; Sun M; Li C; Hou Y; Li X; Meng F; Chen X
Int J Gynecol Cancer; 2011 Jan; 21(1):92-9. PubMed ID: 21330834
[TBL] [Abstract][Full Text] [Related]
37. Treatment of advanced or recurrent squamous cell carcinoma of the uterine cervix with mitomycin-C, bleomycin, and cisplatin chemotherapy.
Smith HO; Stringer CA; Kavanagh JJ; Gershenson DM; Edwards CL; Wharton JT
Gynecol Oncol; 1993 Jan; 48(1):11-5. PubMed ID: 7678571
[TBL] [Abstract][Full Text] [Related]
38. A randomized study of primary bleomycin, vincristine, mitomycin and cisplatin (BOMP) chemotherapy followed by radiotherapy versus radiotherapy alone in stage IIIB and IVA squamous cell carcinoma of the cervix.
Tabata T; Takeshima N; Nishida H; Hirai Y; Hasumi K
Anticancer Res; 2003; 23(3C):2885-90. PubMed ID: 12926129
[TBL] [Abstract][Full Text] [Related]
39. Neoadjuvant chemotherapy and radical surgery in locally advanced cervical cancer. Prognostic factors for response and survival.
Panici PB; Scambia G; Baiocchi G; Greggi S; Ragusa G; Gallo A; Conte M; Battaglia F; Laurelli G; Rabitti C
Cancer; 1991 Jan; 67(2):372-9. PubMed ID: 1702348
[TBL] [Abstract][Full Text] [Related]
40. Concomitant pelvic irradiation, 5-fluorouracil and mitomycin C in the treatment of advanced cervical carcinoma.
Khoury GG; Bulman AS; Joslin CA; Rothwell RI
Br J Radiol; 1991 Mar; 64(759):252-60. PubMed ID: 1902387
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
